Early nodal response as a predictor for necessity of functional neck dissection after chemoradiation

Cancer Journal

Volumn 10, Issue 6, 2004, Pages 339-342

  Vongtama, Roy ^a,b   Lee, Michelle ^a,b   Kim, Brian ^a,b   Sercarz, Joel ^a,c   Lin, Kevin ^a,b   Suchard, Marc A ^a,d   Lee, Steve P ^a,b   Juillard, Guy ^a,b  

^a UCLA ^*

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAISER PERMANENTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Neck dissection; Neoplasms; Radiation therapy; Squamous cell

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM; CISPLATIN; FLUOROURACIL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; LYMPH NODE; NECK DISSECTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TREATMENT RESPONSE; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; DRUG EFFECT; HEAD AND NECK TUMOR; LYMPH NODE METASTASIS; MINIMAL RESIDUAL DISEASE; MORTALITY; RADIATION DOSE; RADIATION EXPOSURE; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES;

EID: 15744369774     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200411000-00002     Document Type: Article

References (7)

1. Mendenhall WM, Villaret DB, Amdur RJ et al. Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 2002;24:1012-1018.
2. Al-Sarraf M, LeBlanc M, Giri PG et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998; 16:1310-1317.
3. Calais G, Alfonsi M, Bardet E et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999; 91:2081-2086.
4. Brizel DM, Prosnitz RG, Hunter S et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;58: 1418-1423.
5. Jaulerry C, Dubray B, Brunin F et al. Prognostic value of tumor regression during radiotherapy for head and neck cancer: a prospective study. Int J Radiat Oncol Biol Phys 1995;33:271-279.
6. Rogers JW, Greven KM, McGuirt WF et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys 2004;58:694-697.
7. Yao M, Graham MM, Hoffman HT et al. The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2004;59:1001-1010.